A man with hyperparathyroidism secondary to kidney failure on peritoneal dialysis underwent a parathyroidectomy with half-gland reimplantation complicated by severe hungry bone syndrome resulting in severe hypocalcaemia, hypotension and QT prolongation on ECG. He was initially managed with oral calcium and intravenous (IV) calcium chloride. Despite standard supportive treatment, attempts to wean IV therapy were unsuccessful. We report the novel use of intraperitoneal calcium to facilitate the weaning of IV calcium and discharge from hospital. A subsequent peritoneal membrane adequacy study did not demonstrate loss of peritoneal membrane adequacy.
LevinABakrisGLMolitchM, et al.Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int2007; 71(1): 31–38.
2.
KettelerMBlockGAEvenepoelP, et al.Executive summary of the 2017 KDIGO Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) Guideline Update: what’s changed and why it matters. Kidney Int2017; 92(1): 26–36.
3.
HoLYWongPNSinHK, et al.Risk factors and clinical course of hungry bone syndrome after total parathyroidectomy in dialysis patients with secondary hyperparathyroidism. BMC Nephrol2017; 18(1): 12.
4.
WitteveenJEVan ThielSRomijnJA, et al.Hungry bone syndrome: still a challenge in the post-operative management of primary hyperparathyroidism: a systematic review of the literature. Eur J Endocrinol2013; 168(3): R45–R53.
5.
AlsafranSShermanSKDahdalehFS, et al.Preoperative calcitriol reduces postoperative intravenous calcium requirements and length of stay in parathyroidectomy for renal-origin hyperparathyroidism. Surgery2019; 165(1): 151–157.
6.
DiethelmAGAdamsPLMuradTM, et al.Treatment of secondary hyperparathyroidism in patients with chronic renal failure by total parathyroidectomy and parathyroid autograft. Ann Surg1981; 193(6): 777.
7.
StraubDA. Calcium supplementation in clinical practice: a review of forms, doses, and indications. Nutr Clin Pract2007; 22(3): 286–296.
8.
LinCYHsiehKCYehMC, et al.Skin necrosis after intravenous calcium chloride administration as a complication of parathyroidectomy for secondary hyperparathyroidism: report of four cases. Surg Today2007; 37(9): 778–781.
9.
BenzRLSchleiferCRTeehanBP, et al.Successful treatment of postparathyroidectomy hypocalcemia using continuous ambulatory intraperitoneal calcium (CAIC) therapy. Perit Dial Int1989; 9(4): 285–288.
10.
ThompsonTJNealeTJ. Intraperitoneal calcium for resistant symptomatic hypocalcaemia after parathyroidectomy in chronic renal failure. Br Med J (Clin Res Ed)1988; 296(6626): 896.
11.
RobinsonAClarkC. Intraperitoneal calcium replacement in a renal transplant recipient not on peritoneal dialysis for severe, persistent hypocalcemia post-parathyroidectomy (Abstract). Nephrology (Carlton)2020; 25: 61.
12.
MiaoCXueXDaiL, et al.The calcium concentration of peritoneal dialysis solution modifies levels of key mediators of peritoneal fibrosis. Semin Dial2021; 34(1): 51–56.
13.
ChristensonMFivushBRacusenL. Safety of intraperitoneal calcium therapy in a rodent model. Adv Perit Dial1992; 8: 15–17.
14.
AdamsonBBByarsJBoyceBF, et al.Mineralisation defects with pamidronate therapy for Paget’s disease. Lancet1993; 342(8885): 1459–1460.
15.
LeeITSheuWHTuST, et al.Bisphosphonate pretreatment attenuates hungry bone syndrome postoperatively in subjects with primary hyperparathyroidism. J Bone Miner Metab2006; 24(3): 255–258.
16.
CorselloSMParagliolaRMLocantoreP, et al.Post-surgery severe hypocalcemia in primary hyperparathyroidism preoperatively treated with zoledronic acid. Hormones (Athens)2010; 9(4): 338–342.
17.
SaluskyIBKuizonBDBelinTR, et al.Intermittent calcitriol therapy in secondary hyperparathyroidism: a comparison between oral and intraperitoneal administration. Kidney Int1998; 54(3): 907–914.
